I agree. I was disappointed that nothing was said by PPHM about free cash flow from AVID ops. I would have been highlighting that. They need to liquidate IP, cut staff, cut costs slim down and become contract manufacture. Cash flow positive. I've seen companies do that and add shareholder value in the process. They're done as a biotech company. They toyed with us seeking the glamour of a biotech. Now its time to morph and actually make some money for us.. Thoughts???